Nobel Biocare is pleased to announce a new distribution partnership with 3Shape, a global leader in 3D scanning and digital dental solutions. Through this collaboration, Nobel Biocare will become an official distributor of 3Shape’s TRIOS intraoral scanners, expanding its digital dentistry portfolio and delivering even greater value to dental professionals worldwide.
3Shape’s TRIOS® scanners are widely recognized for their accuracy, ease of use, and patient-friendly scanning experience. This distribution agreement brings together 3Shape’s innovative scanning technology with Nobel Biocare’s trusted heritage in implant-based restorations and prosthetics, offering customers a streamlined digital workflow from scan to final restoration.
At the same time, we would like to emphasize that the DEXIS IS scanner remains a core element of our offering—an enduring symbol of our strong and strategic partnership with DEXIS. This dual approach not only enhances the range of cutting-edge tools available to dental professionals but also reaffirms our pledge to quality care and innovation, instilling confidence among our customers and key stakeholders, including our valued Envista investors.
“At Nobel Biocare, our mission is to redefine what is possible in dental care by empowering clinicians through innovation,” said Rosemary O’Neill, VP/GM Procera and Digital Solutions. “By partnering with 3Shape and distributing TRIOS scanners, we’re enabling our customers to access one of the most advanced intraoral scanning solutions available, supported by Nobel Biocare’s expertise and service network.”
Key benefits of the partnership include:
Seamless integration of TRIOS scanners with Nobel Biocare’s digital workflows
Bringing together two premium brands to deliver treatment efficiencies, predictability, and reduced time to teeth—transforming patients’ lives through our superior products and solutions
Access to world-class training and educational resources to ensure clinical success
“We are excited to collaborate with Nobel Biocare to expand access to TRIOS,” said John Cusack, Chief Commercial Officer at 3Shape. “This partnership ensures more dental professionals can benefit from a proven digital solution that enhances patient care and practice efficiency.”
TRIOS scanners will be available in select markets for purchase through Nobel Biocare by the end of June 2025.
About Nobel Biocare
Nobel Biocare is a world leader in implant-based dental restorations. Our mission is to empower dental professionals to provide exceptional care through innovative solutions and clinical support.
About 3Shape
3Shape is a global innovator in digital dentistry, empowering dental professionals to provide superior dental care for every patient, every time. Its award-winning digital solutions advance and connect practices and labs. Founded in Denmark in 2000, 3Shape employs more than 2,200 dedicated professionals who serve customers in 100+ countries. Private equity fund EQT has been a shareholder since 2022.
Source: www.3shape.com
Digital Dentistry 10 August 2022
Dental brand company, Envista Holdings Corporations, has extended and expanded its commercial partnership with DSO, dentalcorp Holdings Ltd. Envista company, Nobel Biocare, will also work to support...
News 11 May 2026
Food and Drug Administration (FDA) has granted FDA clearance for its Dx Software following a review completed on April 10, 2026.
News 06 February 2026
3Shape today announced the appointment of Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy, effective 9 March. Rasmus will join the senior leadership team and will report...
News 24 February 2025
3Shape Launches Paradigm Shift in CAD Workflows for Dental Labs
This year at LMT Lab Day, 3Shape celebrates twenty-five years of innovation by introducing a paradigm shift to CAD workflows for dental labs.
3Shape A/S, a global innovator in digital dentistry with its market-leading intraoral (IOS) scanners, and Medit Corp, a leading provider of dental 3D scanners, today announced they have settled U.S....
Products 19 November 2026
FDA Grants Breakthrough Designation to OraLiva Oral Cancer Test
Investigational cytology test is designed to help clinicians assess suspicious oral lesions with a quantitative index.
News 19 November 2026
The Delta Dental Community Care Foundation, the philanthropic arm of Delta Dental of California and its affiliates, announced $16.3 million in Access to Care Grant funding, continu
News 19 November 2026
Henry Schein Announces Upcoming Investor Conference Presentations
(Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the followin
Editorials 19 November 2026
Twenty Florida high school students recently visited the UF College of Dentistry, or UFCD, for a day of programming designed to help them explore potential careers in dentistry.
Periodontology 19 November 2026
This peer-reviewed periodontology article summarizes clinical evidence from Journal of periodontology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions,...